Publications by authors named "Hadar Guthmann"

Claim this Profile
D
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.
Philipp Reus, Hadar Guthmann, Nadja Uhlig, Majd Agbaria, Leila Issmail

J Control Releaseยท December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis